Gold, R., Kappos, L., Palace, J., Siever, A., Marrosu, M., Gottschalk, R., . . . Comi, G. (2012). Cardiac safety of fingolimod 0.5 mg during the first-dose observation in a 4-month, open-label, multicentre FIRST study in relapsing multiple sclerosis patients.
Style de citation Chicago (17e éd.)Gold, R., et al. Cardiac Safety of Fingolimod 0.5 Mg During the First-dose Observation in a 4-month, Open-label, Multicentre FIRST Study in Relapsing Multiple Sclerosis Patients. 2012.
Style de citation MLA (9e éd.)Gold, R., et al. Cardiac Safety of Fingolimod 0.5 Mg During the First-dose Observation in a 4-month, Open-label, Multicentre FIRST Study in Relapsing Multiple Sclerosis Patients. 2012.
Attention : ces citations peuvent ne pas être correctes à 100%.